BIOGEN INC. Public Float
BIOGEN INC. (BIIB) had Public Float of $18.38 billion as of 2025-06-30, per its 10-K filed 2026-02-06.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-06
- 2025-06-30: Entity Public Float $18.38B.
- 2024-06-30: Entity Public Float $33.71B.
- 2023-06-30: Entity Public Float $41.19B.
- 2022-06-30: Entity Public Float $29.40B.
| Period end | Entity Public Float | Entity Public Float as first filed |
|---|---|---|
| 2025-06-30 | $18.38B 10-K · filed 2026-02-06 | |
| 2024-06-30 | $33.71B 10-K · filed 2025-02-12 | |
| 2023-06-30 | $41.19B 10-K · filed 2024-02-14 | |
| 2022-06-30 | $29.40B 10-K · filed 2023-02-15 | |
| 2021-06-30 | $51.26B 10-K · filed 2022-02-03 | |
| 2020-06-30 | $42.10B 10-K · filed 2021-02-03 | |
| 2019-06-30 | $43.01B 10-K · filed 2020-02-06 | |
| 2018-06-30 | $58.27B 10-K · filed 2019-02-06 | |
| 2017-06-30 | $57.22B 10-K · filed 2018-02-01 | |
| 2016-06-30 | $52.84B 10-K · filed 2017-02-02 | |
| 2015-06-30 | $94.90B 10-K · filed 2016-02-03 | |
| 2014-06-30 | $74.39B 10-K · filed 2015-02-04 | |
| 2013-06-30 | $51.09B 10-K · filed 2014-02-06 | |
| 2012-06-30 | $34.14B 10-K · filed 2013-02-05 | |
| 2011-06-30 | $25.91B 10-K · filed 2012-02-03 | |
| 2010-06-30 | $25.91B 10-Q · filed 2011-10-28 | $11.69B 10-Q · filed 2010-07-20 |
| 2009-06-30 | $13.01B 10-Q · filed 2010-04-20 | $13.01B 10-Q · filed 2009-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |